Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/27/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Michael L. Kranda

Wrong Michael L. Kranda?

Chief Executive Officer

Local Address: Seattle, Washington, United States
Company Description: BEAT BioTherapeutics Corp. (BEATBio) is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. Heart...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MBA
  • BA , finance
    University of Washington
166 Total References
Web References
Mr. Kranda, a member of our ...
www.sec.gov, 28 April 2014 [cached]
Mr. Kranda, a member of our Board, is a consultant to Vulcan Capital Venture Capital I LLC.
...
Mr. Kranda does not have voting or investment power over the shares held by Vulcan Ventures Incorporated and its affiliates, and disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
...
Mr. Kranda, a member of our Board, is a consultant to Vulcan Capital Venture Capital I LLC.
...
Mr. Kranda does not have voting or investment power over the shares held by Vulcan Ventures Incorporated and its affiliates, and disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
...
Mr. Kranda, a member of our Board, is a consultant to Vulcan Capital Venture Capital I LLC.
...
Mr. Kranda does not have voting or investment power over the shares held by Vulcan Ventures Incorporated and its affiliates, and disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
...
Mr. Kranda, a member of our Board, is a consultant to Vulcan Capital Venture Capital I LLC.
...
Mr. Kranda does not have voting or investment power over the shares held by Vulcan Ventures Incorporated and its affiliates, and disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
...
Michael Kranda(8)
...
Mr. Kranda, a member of our Board, is a consultant to Vulcan Capital Venture Capital I LLC.
...
Mr. Kranda does not have voting or investment power over the shares held by Vulcan Ventures Incorporated and its affiliates and disclaims beneficial ownership of such shares except to the extent of any beneficial ownership therein.
...
Michael Kranda Audit Committee
...
Mr. Kranda has served as a member of our Board since December 2003. Since September 2006, Mr. Kranda has served as a consultant to Vulcan Capital, the private investment group of Vulcan Inc., and Mr. Kranda served as Managing Director of biotechnology venture investments at Vulcan Capital from September 2003 to September 2006. From July 1996 to July 2002, Mr. Kranda served as Chief Executive Officer at Oxford GlycoSciences, a biotechnology company. Prior to joining Oxford GlycoSciences, Mr. Kranda was President and Chief Operating Officer at Immunex Corporation (now Amgen), a biopharmaceutical company.
...
Mr. Kranda currently serves as Chief Executive Officer and a director of BEAT BioTherapeutics Corporation, a gene therapy company. Mr. Kranda received a B.A. and an M.B.A from the University of Washington School of Business. We believe that Mr. Kranda is qualified to serve on our Board because of his many years of service as one of our directors, his extensive experience in the life sciences industry and his service on the boards of directors of other life sciences companies.
Michael Kranda, MBA - Chief ...
beatbiotherapeutics.com, 24 April 2014 [cached]
Michael Kranda, MBA - Chief Executive Officer - Mr. Kranda has over 25 years of biotech operating, finance and corporate development experience. Most recently Mr. Kranda was CEO of Vaccinogen, a cancer vaccine company. Mr. Kranda served as Managing Director of Vulcan Capital for several years, where he led all aspects of their Life Sciences investment efforts. Mr. Kranda was also the CEO of Oxford GlycoSciences, a pioneer in proteomic based drug and diagnostic product development.
...
Mr. Kranda started his biotech career at Immunex Corporation where he served as President, COO and Director and is currently a Director for PTC Therapeutics, Inc. (NASDAQ: PTCT).
...
Michael Kranda - Chief Executive Officer.
PTC Therapeutics: Michael Kranda
www.ptcbio.com, 5 Oct 2012 [cached]
Home > About Us > Leadership > Board of Directors > Michael Kranda Email Page Print SHARE THIS PAGE:
...
Michael Kranda
...
Michael Kranda
Vulcan Ventures, Inc.
Michael Kranda has been a member of PTC's board of directors since December 2003. Mr. Kranda is currently CEO, President and director of Anesiva, a publically traded biotech company in South San Francisco, CA. Prior to joining Anesiva, Mr. Kranda led life science venture investments as managing director for Vulcan Capital, and continues to serve as a consultant. From July 1996 to July 2002, Mr. Kranda served as Chief Executive Officer at Oxford GlycoSciences, a publically traded biotechnology company headquartered in London. Prior to joining Oxford GlycoSciences, Mr. Kranda was President and Chief Operating Officer at Immunex Corporation (now Amgen).
...
Mr. Kranda received his B.A. and M.B.A from University of Washington School of Business.
Anesiva » Board of Directors
www.anesiva.com, 9 June 2010 [cached]
Michael L. Kranda Anesiva > Board of Directors Board of Directors
Board of Directors
Michael L. Kranda, President & Chief Executive Officer
Michael Kranda joined Anesiva as President and Chief Executive Officer in June of 2008. Prior to Anesiva, Mr. Kranda led life sciences venture investments as Managing Director for Vulcan Capital through 2006 and continues to consult for Vulcan. From July 1996 to July 2002, Mr. Kranda served as chief executive officer at Oxford GlycoSciences, establishing the biotechnology company as the leading proteomics platform-based drug discovery company. Prior to joining Oxford GlycoSciences, Mr. Kranda was President and Chief Operating Officer at Immunex Corporation (now Amgen), where he served as president and chief operating officer and was responsible for sales and marketing, manufacturing and operations. Mr. Kranda serves on the boards of PTC Therapeutics, Cumbre Pharmaceuticals, BiPar Sciences, Nura, Inc., Raven Biotechnologies and the Washington State Biotechnology Business Association. Mr. Kranda received his B.A. and M.B.A from University of Washington School of Business.
...
Michael L. Kranda
Healthcare Sales & Marketing Network: Medical Device and Pharmaceutical News (HSMN NewsFeed)
salesandmarketingnetwork.com, 1 June 2008 [cached]
Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors
Other People with the name "Kranda":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304